中国胸心血管外科临床杂志

中国胸心血管外科临床杂志

经导管介入治疗三尖瓣病变装置的研究进展

查看全文

随着经导管介入主动脉瓣置换及二尖瓣修复等产品逐渐应用于临床,不少研究者相继开发了各种三尖瓣介入治疗的装置。本文将对目前公开报道的有关经导管治疗三尖瓣病变装置进行综述,重点介绍装置结构及部分早期临床结果。相信随着研究的深入,经导管治疗三尖瓣病变技术会不断完善,为患者提供安全、微创的治疗手段。

Recently, several transcatheter devices for aortic valve replacement and mitral valve repair have been used in clinic, and researchers have designed a variety of tricuspid valve (TV) intervention devices. We reviewed the current status of transcatheter TV intervention, and focused on the structures of these devices and the early results of clinical trials. Undoubtedly, transcatheter intervention for TV is promising, innovational and safe for patients with severe TV regurgitation.

关键词: 三尖瓣反流; 经导管治疗; 介入

Key words: Tricuspid valve regurgitation; transcatheter therapy; intervention

引用本文: 吕彦萌, 陆方林. 经导管介入治疗三尖瓣病变装置的研究进展. 中国胸心血管外科临床杂志, 2018, 25(4): 345-349. doi: 10.7507/1007-4848.201705027 复制

登录后 ,请手动点击刷新查看全文内容。 没有账号,
登录后 ,请手动点击刷新查看图表内容。 没有账号,
1. 王湘, 卢耀星, 李刚, 等. 对三尖瓣反流的评估及处理的意义和方法. 中国胸心血管外科临床杂志, 2016, 23(2): 183-186.
2. Muraru D, Surkova E, Badano LP. Revisit of functional tricuspid regurgitation; current trends in the diagnosis and management. Korean Circ J, 2016, 46(4): 443-455.
3. Igarashi T, Tanji M, Takahashi K, et al. Predictive factor of secondary tricuspid regurgitation after aortic valve replacement for aortic stenosis: the importance of myocardial hypertrophy and diastolic dysfunction. Gen Thorac Cardiovasc Surg, 2017, 65(5): 259-266.
4. Takano H, Hiramatsu M, Kida H, et al. Severe tricuspid regurgitation after mitral valve surgery: the risk factors and results of the aggressive application of prophylactic tricuspid valve repair. Surg Today, 2017, 47(4): 445-456.
5. Jang JY, Heo R, Lee S, et al. Comparison of results of tricuspid valve repair versus replacement for severe functional tricuspid regurgitation. Am J Cardiol, 2017, 119(6): 905-910.
6. Rodés-Cabau J, Taramasso M, O'Gara PT. Diagnosis and treatment of tricuspid valve disease: current and future perspectives. Lancet, 2016, 388(10058): 2431-2442.
7. Jabbour RJ, Giannini F, Tanaka A, et al. Advances in percutaneous interventional therapies: the tricuspid valve. Future Cardiol, 2017, 13(3): 239-245.
8. Auffret V, Lefevre T, Van Belle E, et al. Temporal trends in transcatheter aortic valve replacement in france: FRANCE 2 to FRANCE TAVI. J Am Coll Cardiol, 2017, 70(1): 42-55.
9. Rogers T, Torguson R, Bastian R, et al. Feasibility of transcatheter aortic valve replacement in low-risk patients with symptomatic severe aortic stenosis: Rationale and design of the Low Risk TAVR (LRT) study. Am Heart J, 2017, 189: 103-109.
10. Alozie A, Paranskaya L, Westphal B, et al. Clinical outcomes of conventional surgery versus MitraClip® therapy for moderate to severe symptomatic mitral valve regurgitation in the elderly population: an institutional experience. BMC Cardiovasc Disord, 2017, 17(1): 85.
11. Luo X, Wang X, Li X, et al. Transapical transcatheter aortic valve implantation using the J-Valve system: A 1-year follow-up study. J Thorac Cardiovasc Surg, 2017, 154(1): 46-55.
12. Liao YB, Zhao ZG, Wei X, et al. Transcatheter aortic valve implantation with the self-expandable venus A-Valve and CoreValve devices: preliminary experiences in China. Catheter Cardiovasc Interv, 2017, 89(S1): 528-533.
13. Brüstle K, Calen C, Kuwata S, et al. How to treat tricuspid valve disease: what's new on the horizon. Curr Treat Options Cardiovasc Med, 2017, 19(3): 18.
14. Lauten A, Ferrari M, Hekmat K, et al. Heterotopic transcatheter tricuspid valve implantation: first-in-man application of a novel approach to tricuspid regurgitation. Eur Heart J, 2011, 32(10): 1207-1213.
15. Rodés-Cabau J, Hahn RT, Latib A, et al. Transcatheter therapies for treating tricuspid regurgitation. J Am Coll Cardiol, 2016, 67(15): 1829-1845.
16. Lauten A, Doenst T, Hamadanchi A, et al. Percutaneous bicaval valve implantation for transcatheter treatment of tricuspid regurgitation: clinical observations and 12-month follow-up. Circ Cardiovasc Interv, 2014, 7(2): 268-272.
17. Schulz E, Jabs A, Tamm A, et al. Comparison of transcatheter aortic valve implantation with the newest-generation Sapien 3 vs. Direct Flow Medical valve in a single center cohort. Int J Cardiol, 2017, 232: 186-191.
18. Laule M, Stangl V, Sanad W, et al. Percutaneous transfemoral management of severe secondary tricuspid regurgitation with Edwards Sapien XT bioprosthesis: first-in-man experience. J Am Coll Cardiol, 2013, 61(18): 1929-1931.
19. Scarsini R, Lunardi M, Pesarini G, et al. Long-term follow-up after trans-catheter tricuspid valve-in-valve replacement with balloon-expandable aortic valves. Int J Cardiol, 2017, 235: 141-146.
20. Lausberg HF, Gryszkiewicz R, Kuetting M, et al. Catheter-based tricuspid valve replacement: first experimental data of a newly designed bileaflet stent graft prosthesis. Eur J Cardiothorac Surg, 2017.
21. 范阜东, 何孝军, 潘俊, 等. 左心系统瓣膜术后再次行三尖瓣手术的临床疗效分析. 中国胸心血管外科临床杂志, 2016, 23(8): 784-787.
22. Schueler R, Nickenig G. The Mitralign: strategies for optimal patient selection and optimised results. EuroIntervention, 2016, 12(Y): Y67-Y69.
23. Schofer J, Bijuklic K, Tiburtius C, et al. First-in-human transcatheter tricuspid valve repair in a patient with severely regurgitant tricuspid valve. J Am Coll Cardiol, 2015, 65(12): 1190-1195.
24. Hahn RT, Meduri CU, Davidson CJ, et al. Early feasibility study of a transcatheter tricuspid valve annuloplasty: SCOUT trial 30-day results. J Am Coll Cardiol, 2017, 69(14): 1795-1806.
25. Latib A, Agricola E, Pozzoli A, et al. First-in-man implantation of a tricuspid annular remodeling device for functional tricuspid regurgitation. JACC Cardiovasc Interv, 2015, 8(13): e211-214.
26. Calen C, Taramasso M, Guidotti A, et al. Successful tricinch-in-tricinch transcatheter tricuspid valve repair. JACC Cardiovasc Interv, 2017, 10(8): e75-e77.
27. Rogers T, Ratnayaka K, Sonmez M, et al. Transatrial intrapericardial tricuspid annuloplasty. JACC Cardiovasc Interv, 2015, 8(3): 483-491.
28. Kuwata S, Taramasso M, Nietlispach F, et al. Transcatheter tricuspid valve repair toward a surgical standard: first-in-man report of direct annuloplasty with a cardioband device to treat severe functional tricuspid regurgitation. Eur Heart J, 2017, 38(16): 1261.
29. Von Bardeleben RS. Cardioband Tricuspid: A new era and gold standard through catheter. Italia: Joint Interventional Meeting 2017, 2017.
30. Rogers JH. Transcatheter tricuspid valve therapies 5: millipede. description, results and a case. USA: Transcatheter Cardiovascular Therapeutics 2016, 2016.
31. Campelo-Parada F, Perlman G, Philippon F, et al. First-in-man experience of a novel transcatheter repair system for treating severe tricuspid regurgitation. J Am Coll Cardiol, 2015, 66(22): 2475-2483.
32. Rahhab Z, Kortlandt FA, Velu JF, et al. Current MitraClip experience, safety and feasibility in the Netherlands. Neth Heart J, 2017, 25(6): 394-400.
33. Nickenig G, Kowalski M, Hausleiter J, et al. Transcatheter treatment of severe tricuspid regurgitation with the edge-to-edge MitraClip technique. Circulation, 2017, 135(19): 1802-1814.
34. McElhinney DB, Cabalka AK, Aboulhosn JA, et al. Transcatheter tricuspid valve-in-valve implantation for the treatment of dysfunctional surgical bioprosthetic valves: an international, multicenter registry study. Circulation, 2016, 133(16): 1582-1593.
35. 薛清, 徐志云, 韩林, 等. 二尖瓣成形术中轻度功能性三尖瓣反流的处理. 中国胸心血管外科临床杂志, 2011, 18(6): 503-506.
36. Huttin O, Voilliot D, Mandry D, et al. All you need to know about the tricuspid valve: Tricuspid valve imaging and tricuspid regurgitation analysis. Arch Cardiovasc Dis, 2016, 109(1): 67-80.